To assess whether there was any correlation between ER/PR/HER2 presence, or histologic subtype of breast cancer, and HPA labeling, we collated the HPA labelling patterns across a number of breast cancer cell lines reported in the literature and did not find any correlation between HPA labeling and receptor status or histologic subtype (Supplementary Table 5). Here, ERBB2 is linked to breast cancer.